PL1926477T3 - Kompozycja zawierająca NLPZ oraz paracetamol - Google Patents

Kompozycja zawierająca NLPZ oraz paracetamol

Info

Publication number
PL1926477T3
PL1926477T3 PL06779316T PL06779316T PL1926477T3 PL 1926477 T3 PL1926477 T3 PL 1926477T3 PL 06779316 T PL06779316 T PL 06779316T PL 06779316 T PL06779316 T PL 06779316T PL 1926477 T3 PL1926477 T3 PL 1926477T3
Authority
PL
Poland
Prior art keywords
paracetamol
composition containing
containing nsaids
nsaids
composition
Prior art date
Application number
PL06779316T
Other languages
English (en)
Polish (pl)
Inventor
Robert Sherry
Original Assignee
Reckitt Benckiser Healthcare (Uk) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35335274&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1926477(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Reckitt Benckiser Healthcare (Uk) Limited filed Critical Reckitt Benckiser Healthcare (Uk) Limited
Publication of PL1926477T3 publication Critical patent/PL1926477T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/67Phosphorus compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL06779316T 2005-09-22 2006-09-07 Kompozycja zawierająca NLPZ oraz paracetamol PL1926477T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0519350.3A GB0519350D0 (en) 2005-09-22 2005-09-22 Therapeutic agents

Publications (1)

Publication Number Publication Date
PL1926477T3 true PL1926477T3 (pl) 2017-09-29

Family

ID=35335274

Family Applications (2)

Application Number Title Priority Date Filing Date
PL06779316T PL1926477T3 (pl) 2005-09-22 2006-09-07 Kompozycja zawierająca NLPZ oraz paracetamol
PL14199017T PL2851068T3 (pl) 2005-09-22 2006-09-07 Kompozycja zawierająca NLPZ oraz paracetamol

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL14199017T PL2851068T3 (pl) 2005-09-22 2006-09-07 Kompozycja zawierająca NLPZ oraz paracetamol

Country Status (13)

Country Link
US (1) US20090142392A1 (https=)
EP (2) EP1926477B1 (https=)
JP (1) JP2009508916A (https=)
KR (2) KR101434906B1 (https=)
CN (1) CN101267807B (https=)
AU (1) AU2006293798B2 (https=)
CA (1) CA2623281A1 (https=)
GB (1) GB0519350D0 (https=)
PL (2) PL1926477T3 (https=)
RU (1) RU2438656C2 (https=)
SG (1) SG149080A1 (https=)
WO (1) WO2007034135A1 (https=)
ZA (1) ZA200802436B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007000117A (es) 2004-07-07 2007-06-15 Aft Pharmaceuticals Ltd Una composicion de combinacion.
GB2447898B (en) * 2007-03-24 2011-08-17 Reckitt Benckiser Healthcare A tablet having improved stability with at least two actives
PE20091550A1 (es) * 2008-01-11 2009-10-03 Cipla Ltd Composicion farmaceutica extruida/granulada en caliente
WO2009128543A1 (ja) * 2008-04-17 2009-10-22 ニプロ株式会社 シリカを含む錠剤の製造方法、錠剤及び錠剤用複合粒子
JP2012505830A (ja) * 2008-10-14 2012-03-08 エイエフティ ファーマスーティカルズ リミテッド 医薬品及び医薬品治療
ES2365961B1 (es) * 2010-03-30 2013-01-24 Farmasierra Manufacturing S.L. Formulación farmacéutica a base de ibuprofeno y codeína de estabilidad mejorada.
CN105816434B (zh) * 2016-04-19 2019-09-17 山东新华制药股份有限公司 布洛芬颗粒及其制备方法
EP3700509B1 (en) 2017-11-29 2023-11-22 Ilko Ilaç Sanayi Ve Ticaret Anonim Sirketi Color stable fixed dose tablet combination of ibuprofen and paracetamol
US20190350883A1 (en) * 2018-05-20 2019-11-21 Luan Chau Pharmaceutical Composition of Acetaminophen/Ibuprofen
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
US11779541B2 (en) 2019-03-26 2023-10-10 Johnson & Johnson Consumer Inc. Immediate release dosage form
BR112021026407A8 (pt) * 2019-06-27 2022-11-22 Pf Consumer Healthcare 1 Llc Composição de ibuprofeno e acetaminofeno
CN110372713B (zh) * 2019-08-15 2022-05-17 广州市汉普医药有限公司 一种普拉洛芬的精制纯化方法
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5271811A (en) * 1988-01-29 1993-12-21 Hoechst Celanese Corporation Process for purifying 2-(4-isobutylphenyl)-propionic acid by vacuum distillation
DE3802619C1 (https=) 1988-01-29 1989-09-07 Hoechst Ag, 6230 Frankfurt, De
DE3833448A1 (de) 1988-10-01 1990-04-12 Hoechst Ag Verfahren zur gewinnung von ibuprofen fuer die direkttablettierung
US5409709A (en) * 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
JP3122748B2 (ja) * 1991-11-29 2001-01-09 ライオン株式会社 イブプロフェン含有解熱鎮痛剤
DE4418837A1 (de) * 1994-05-30 1995-12-07 Bayer Ag Thermisches Granulierverfahren
DE4446468A1 (de) * 1994-12-23 1996-06-27 Basf Ag Verfahren zur Herstellung von umhüllten Tabletten
JP3982889B2 (ja) * 1997-11-28 2007-09-26 あすか製薬株式会社 イブプロフェン含有医薬製剤
US6787157B1 (en) * 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
RU2192248C2 (ru) * 1998-07-13 2002-11-10 Товарищество с ограниченной ответственностью фирма "Эйкос" Препарат "антигриппин"
DK1235558T3 (da) * 1999-12-09 2006-10-09 Reckitt Benckiser Healthcare Sammenpresset tabletsammensætning, der omfatter et NSAID
GB0113841D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
RU2237470C1 (ru) * 2003-01-27 2004-10-10 Купсин Евгений Вениаминович Комбинированный препарат для устранения симптомов простудных заболеваний и гриппа (варианты)
US20040265378A1 (en) * 2003-06-25 2004-12-30 Yingxu Peng Method and compositions for producing granules containing high concentrations of biologically active substances
WO2006016126A1 (en) * 2004-08-12 2006-02-16 Reckitt Benckiser Healthcare (Uk) Limited Granules comprising paracetamol a nsaid and a sugar alcohol made by melt extrusion
GB0423103D0 (en) * 2004-10-19 2004-11-17 Boots Healthcare Int Ltd Therapeutic agents

Also Published As

Publication number Publication date
CN101267807A (zh) 2008-09-17
AU2006293798A1 (en) 2007-03-29
AU2006293798B2 (en) 2012-08-16
EP1926477A1 (en) 2008-06-04
KR20080047437A (ko) 2008-05-28
CA2623281A1 (en) 2007-03-29
US20090142392A1 (en) 2009-06-04
KR20130141728A (ko) 2013-12-26
EP2851068A3 (en) 2015-05-27
GB0519350D0 (en) 2005-11-02
RU2008115507A (ru) 2009-10-27
WO2007034135A1 (en) 2007-03-29
CN101267807B (zh) 2013-04-10
EP2851068B1 (en) 2019-10-23
EP2851068A2 (en) 2015-03-25
JP2009508916A (ja) 2009-03-05
EP1926477B1 (en) 2017-04-19
KR101434906B1 (ko) 2014-08-27
SG149080A1 (en) 2009-01-29
ZA200802436B (en) 2009-07-29
PL2851068T3 (pl) 2020-04-30
RU2438656C2 (ru) 2012-01-10

Similar Documents

Publication Publication Date Title
HUS1400051I1 (hu) Lurazidont tartalmazó gyógyászati készítmény
EP1967126A4 (en) CONTAINER DEVICE
BRPI0613033A2 (pt) composição oral
DK1961744T3 (da) Forbindelse indeholdende basiske grupper samt anvendelse deraf
DK2079485T3 (da) Phenylpropionamidforbindelser og anvendelsen deraf
EP1788047A4 (en) WATER REPELLENT / OIL-REPELLING COMPOSITION
PT1920065T (pt) Anticorpos anti-alfavbeta6 e suas utilizações
PL1954684T3 (pl) Związek oksazolowy i kompozycja farmaceutyczna
CR20130381A (es) Formas farmacéuticas con propiedades farmacocinéticas mejoradas
NO20055686D0 (no) Sammensetning
DK2001556T3 (da) Thioninium-forbindelser og anvendelse deraf
EP1903334A4 (en) BIOSENSOR
EP1930376A4 (en) POLYMERIZABLE COMPOSITION
PL2851068T3 (pl) Kompozycja zawierająca NLPZ oraz paracetamol
FR2885520B1 (fr) Composition cosmetique
EP1909098A4 (en) BIOSENSOR
DK1741339T3 (da) Pesticid sammensætning
EP1862506A4 (en) ANTISTATIC COMPOSITION
DE602006009980D1 (de) Biosensor
DE602006015667D1 (de) Flammwidrige zusammensetzung
DE602005017191D1 (de) Geruchsreduzierte waschstück-zusammensetzung
EP1854460A4 (en) OUTER PLASTER WITH FLURBIPROFEN
FR2881342B1 (fr) Composition demaquillante
BRPI0810057A2 (pt) Composição farmacêutica contendo floroglucinol e paracetamol
FR2871686B1 (fr) Composition anti-decoloration